Tocalfa 50 000 IU + 50 mg 20 soft capsules

Tocalfa 50,000 IU + 50 mg 20 softgels is a vitamin supplement for oral use, formulated to support the body in conditions associated with deficiencies of Vitamin A and Vitamin E. Each capsule contains 50,000 IU of retinol esters (Vitamin A) and 50 mg of d,l alpha-tocopheryl acetate (Vitamin E) , two essential nutrients for the correct functioning of the immune system, the protection of cells from oxidative stress and the maintenance of healthy skin, vision and mucous membranes.

Vitamin A (retinol) is essential for vision , cell growth and immune defense, while Vitamin E (tocopherol) plays a key role as an antioxidant , helping to protect cell membranes from free radical damage. Tocalfa is particularly indicated for the prevention and treatment of vitamin deficiencies that can arise following nutrient-poor diets, intestinal malabsorption, periods of convalescence or increased need.

The package contains 20 soft capsules , easy to swallow, ideal for targeted therapeutic cycles that can be repeated throughout the year as needed. Produced by Difa Cooper , Tocalfa stands out for its high concentration of active ingredients and the quality of its formulation, making it a reliable choice for those who need specific vitamin support in the event of vitamin A and vitamin E deficiency . The supplement is suitable as a self-medication drug and can be used under medical supervision for limited periods, based on individual needs.

ACTIVE INGREDIENTS

Active substances contained in Tocalfa 50 000 IU + 50 mg 20 soft capsules - What is the active substance of Tocalfa 50 000 IU + 50 mg 20 soft capsules?

1 soft capsule of approx. 0.271 g contains: Active ingredients: Retinol esters concentrated solution UI 50,000 d,l alpha - Tocopheryl acetate. mg 50

EXCIPIENTS

Composition of Tocalfa 50 000 IU + 50 mg 20 soft capsules - What does Tocalfa 50 000 IU + 50 mg 20 soft capsules contain?

Oil for injection Gelatin Glycerol Ethyl p-hydroxybenzoate sodium Propyl p-hydroxybenzoate sodium

DIRECTIONS

Therapeutic indications Tocalfa 50 000 IU + 50 mg 20 soft capsules - Why is Tocalfa 50 000 IU + 50 mg 20 soft capsules used? What is it used for?

Conditions associated with Vitamin A and E deficiency states.

CONTRAINDICATIONS AND SIDE EFFECTS

Contraindications Tocalfa 50 000 IU + 50 mg 20 soft capsules - When should Tocalfa 50 000 IU + 50 mg 20 soft capsules not be used?

Known hypersensitivity to the components.

DOSAGE

Quantity and method of taking Tocalfa 50 000 IU + 50 mg 20 soft capsules - How to take Tocalfa 50 000 IU + 50 mg 20 soft capsules?

1 - 2 soft capsules per day. For cycles of 30-90 days interspersed with appropriate suspension periods. The therapeutic cycle can be repeated during the year if necessary. In very prolonged therapies, especially if for several years, do not exceed the number and duration of therapeutic cycles recommended for each year, in order to avoid the risk of chronic vitamin A overdose.

CONSERVATION

Storage Tocalfa 50 000 IU + 50 mg 20 soft capsules - How is Tocalfa 50 000 IU + 50 mg 20 soft capsules stored?

None.

WARNINGS

Warnings Tocalfa 50 000 IU + 50 mg 20 soft capsules - About Tocalfa 50 000 IU + 50 mg 20 soft capsules it is important to know that:

Very high doses of Vitamin A in animals are teratogenic and have been associated in isolated cases with malformations in humans. Keep out of reach of children. In order to avoid the appearance of signs and symptoms of overdose, use the product under medical supervision and for the period of time deemed strictly necessary. Preparations containing vitamin E must be used with caution in diabetics and subjects with heart failure since this vitamin can reduce the need for insulin and digitalis.

INTERACTIONS

Interactions Tocalfa 50 000 IU + 50 mg 20 soft capsules - Which medicines or foods can modify the effect of Tocalfa 50 000 IU + 50 mg 20 soft capsules?

Vitamin E may enhance the action of digitalis or insulin.

SIDE EFFECTS

Like all medicines, Tocalfa 50 000 IU + 50 mg 20 soft capsules can cause side effects - What are the side effects of Tocalfa 50 000 IU + 50 mg 20 soft capsules?

The product used at the recommended doses is generally well tolerated; only in case of continuous administration and at high doses may signs and symptoms of hypervitaminosis A appear (anorexia, hepatosplenomegaly, skin disorders, etc.).

OVERDOSE

Overdose Tocalfa 50 000 IU + 50 mg 20 soft capsules - What are the risks of Tocalfa 50 000 IU + 50 mg 20 soft capsules in case of overdose?

No cases of overdose of Tocalfa have been described. However, cases of acute overdose of vitamin A have been described in children (headaches, nausea, vomiting, drowsiness, irritability, itching); the symptoms regress within 72 hours of intake. In adults, it is extremely unlikely that single doses, even high ones, can cause hypervitaminosis A. Prolonged administration of excessive doses of vitamin A causes the onset of toxic manifestations of hypervitaminosis A both in children (hyperostosis, alopecia, nausea, vomiting) and in adults (asthenia, anorexia, skin desquamation, bone and joint pain). Suspension of administration is sufficient to stop the evolution of the symptoms, which in any case regress more or less slowly depending on the symptoms.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Tocalfa 50,000 IU + 50 mg 20 soft capsules.

Daily amounts of vitamin A higher than 10,000 IU should be avoided during pregnancy (especially in the first months) and you should consult your doctor for advice on the total amount of vitamin A that can be taken from different sources. The product, containing vitamin A in high doses, should therefore not be used during pregnancy.

DRIVING AND USE OF MACHINERY

Taking Tocalfa 50 000 IU + 50 mg 20 soft capsules before driving or using machines - Does Tocalfa 50 000 IU + 50 mg 20 soft capsules affect driving or using machines?

No negative effects of the preparation on these activities are reported or expected.